Author:
Vanbelleghem E,Taelman T,Werbrouck J,Libbrecht L,D’Heygere F
Abstract
This case report describes a 52-year-old male patient with important weight loss, fatigue, diarrhea and a skin eruption since 1 year. Olmesartan-induced enteropathy and skin vasculitis were diagnosed. The onset of symptoms occurred almost two years after the initiation of the angiotensin receptor blocker therapy. There was a total resolution of the symptoms after the cessation of olmesartan. Although sprue-like enteropathy and cutaneous vasculitis are very rare, clinicians should be aware of those potential adverse events, even years after the initiation of an angiotensin II receptor blocker.
Reference15 articles.
1. RUBIO-TAPIA A., HERMAN ML., LUDVIGSSON JF., KELLY DG., MANGAN TF., Wu TT., et. al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc., 2012, 87(8):732-738.
2. HUJOEL IA., RUBIO-TAPIA A., Sprue-like enteropathy associated with olmesartan: a new kid on the enteropathy block. GE Port J Gastroenterol., 2016, 23: 61-65.
3. CHOI EY., McKENNA BJ. Olmesartan-associated enteropathy: a review of clinical and histologic findings. Arch Pathol Lab Med., 2015, 139: 1242-1247.
4. KEMPENAERS S., BOGAERT J., DE MAEYER M., VAN HAUTHEM P., RAMAEL M., SCHOETERS P., Olmesartan-induced enteropathy treated with budesonide. Acta Gastroenterol Belg., 2019, 82(2):319-321.
5. EUSEBIO M., CALDEIRA P., ANTUNES AG., ROMAS A., VELASCO F., CADILLA J., et al. Olmesartan-induced enteropathy: an unusual cause of villous atrophy. GE Port J. Gastroenterol., 2016, 23: 91-95.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献